Compare AstraZeneca plc (AZN) vs MINISO Group Holding Ltd (MNSO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs MINISO Group Holding Ltd — how do they compare? AstraZeneca plc trades at $158.47 (market cap $248.14B), while MINISO Group Holding Ltd trades at $11.93 (market cap $3.62B). The key difference: AstraZeneca plc is far larger — about 68.5× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays the higher dividend (5.53%). Which is the better fit depends on your goals.
| AZN | MNSO | |
|---|---|---|
Market Cap | $248.14B | $3.62B |
Sector | Health | Technology |
52-Week High | $209.48 | $26.63 |
52-Week Low | $147.06 | $11.30 |
Enterprise Value | $275.41B | $4.29B |
Dividend Yield | 2.01% | 5.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $158.48, down 2.12% amid bearish technical signals and merger speculation. The stock shows strong fundamentals with revenue growth from $54.1B in 2024 to $58.7B in 2025 and net income reaching $10.2B. Recent earnings beats and a 47.5% analyst buy rating contrast with technical indicators showing oversold conditions near key support at $155.
Investment outlook remains positive based on earnings momentum and valuation metrics (P/E 23.76), though risks include potential merger integration challenges and ongoing legal investigations. The company's robust cash flow generation and dividend payments provide shareholder value support despite near-term volatility.
MNSO trades at $11.9, down 4.95% in the last session, with technical indicators showing a neutral to bearish bias. Recent earnings show volatility, with a Q1 2026 beat but prior misses, while fundamentals reveal solid revenue growth and improving profitability. The company announced a HK$2 billion share repurchase program in June 2026, signaling confidence.
The outlook is mixed: strong analyst buy ratings (75%) and undervalued metrics like a P/E of 12.16 support upside, but recent price declines and competitive pressures pose risks. Earnings consistency and margin sustainability are key for investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →
